PINGTAN MARINE ENTERPRISE LT (PME)

KYG7114V1023 - Common Stock

0.27  -0.02 (-6.9%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PME. PME was compared to 92 industry peers in the Food Products industry. Both the profitability and financial health of PME have multiple concerns. While showing a medium growth rate, PME is valued expensive at the moment.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PME has reported negative net income.
In the past year PME had a positive cash flow from operations.
In multiple years PME reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PME reported negative operating cash flow in multiple years.

1.2 Ratios

PME has negative profitability rations, so we won't be analyzing them here.
Looking at the Return On Invested Capital, with a value of 6.76%, PME is in the better half of the industry, outperforming 71.74% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PME is below the industry average of 7.56%.
The last Return On Invested Capital (6.76%) for PME is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.76%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.02%
ROIC(5y)N/A

1.3 Margins

With an excellent Operating Margin value of 17.81%, PME belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
PME's Operating Margin has declined in the last couple of years.
PME does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 17.81%
PM (TTM) N/A
GM N/A
OM growth 3Y-25.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PME is still creating some value.
Compared to 1 year ago, PME has more shares outstanding
The debt/assets ratio for PME has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that PME is in the distress zone and has some risk of bankruptcy.
PME has a worse Altman-Z score (0.30) than 73.91% of its industry peers.
The Debt to FCF ratio of PME is 25.89, which is on the high side as it means it would take PME, 25.89 years of fcf income to pay off all of its debts.
PME has a Debt to FCF ratio (25.89) which is in line with its industry peers.
PME has a Debt/Equity ratio of 2.77. This is a high value indicating a heavy dependency on external financing.
PME has a worse Debt to Equity ratio (2.77) than 90.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF 25.89
Altman-Z 0.3
ROIC/WACC1.51
WACC4.49%

2.3 Liquidity

A Current Ratio of 0.75 indicates that PME may have some problems paying its short term obligations.
PME's Current ratio of 0.75 is on the low side compared to the rest of the industry. PME is outperformed by 85.87% of its industry peers.
A Quick Ratio of 0.50 indicates that PME may have some problems paying its short term obligations.
PME has a worse Quick ratio (0.50) than 77.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.5

More info and screens

4

3. Growth

3.1 Past

PME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.01%, which is quite impressive.
The Revenue has grown by 88.08% in the past year. This is a very strong growth!
PME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.59% yearly.
EPS 1Y (TTM)96.01%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-5925.81%
Revenue 1Y (TTM)88.08%
Revenue growth 3Y36.65%
Revenue growth 5Y51.59%
Revenue growth Q2Q95.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PME indicates a rather cheap valuation: PME is cheaper than 85.87% of the companies listed in the same industry.
PME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PME is cheaper than 94.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.67
EV/EBITDA 6.97

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PINGTAN MARINE ENTERPRISE LT

NASDAQ:PME (2/28/2023, 7:00:00 PM)

0.27

-0.02 (-6.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap23.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 17.81%
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.75
Quick Ratio 0.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)96.01%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)88.08%
Revenue growth 3Y36.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y